The pharmaceutical company Tibotec said it will join with the non-profit Global Alliance for Tuberculosis Development (TB Alliance) to speed up the development of the experimental TB drug TMC207, Health-e/IOL reports.
South African AIDS activist Thembi Ngubane recently died of drug-resistant tuberculosis at the age of 24, the AP/Washington Post reports.
Recent Releases: HIV Prevention; Clinical Trials Debate; Definition Of Global Health; Drug Resistant TB
Future Studies Needed To Determine If ‘Test And Treat’ Approach Could ‘End HIV Pandemic Within 50 Years,’ Researchers Say In a Journal of the American Medical Association commentary piece, Anthony Fauci and Carl Dieffenbach of the National Institute of Allergy and Infectious Diseases explore results from a WHO mathematical model…
South African President Jacob Zuma on Wednesday said he wants to have 80 percent of HIV-positive South Africans who need antiretrovirals (ARVs) on them by 2011, BuaNews reports.
Lancet Study Finds No Association Between Human-Rights Treaties and Health Status The ratification of primary human-rights treaties is not associated with health status changes, according to a team of Canadian researchers, who add the findings “should not be interpreted to mean that human-rights treaties have no effect on important health…
The Economist examines how mobile phones could be used to detect the spread of diseases worldwide.
A new two-year trial to test a tuberculosis vaccine aimed at boosting the efficacy of the BCG vaccine is scheduled to begin soon in South Africa, IRIN reports.
Also in Global Health News: U.N. Asks For IDP Aid; Gates On Polio & HIV/AIDS Vaccine; AIDS Cases Triple In Indonesia; Drugs In Kenya, Uganda & Liberia
U.N. Agencies, NGOs Appeal For $37M For IDPs In Pakistan The WHO, UNICEF, the U.N. Population Fund and 19 NGOs have appealed for $37 million to provide “life-saving healthcare” for more than three million internally displaced people currently residing in temporary camps in northwest Pakistan, the International News reports. The…
A Johnson & Johnson-run study found that its experimental drug TMC207 could make conventional tuberculosis treatment five times more effective against multi-drug resistant TB (MDR-TB) because it cleared traces of the TB bacteria in the sputum of 48 percent of study volunteers after eight weeks, Reuters reports.
According to a report released Tuesday by Medicins Sans Frontiers (MSF), “Zimbabweans continue to cross the border [into South Africa] every day, legally and illegally, in massive numbers as a matter of survival,” AFP/Google.com reports.